Minnesota · 2025-2026 Regular Session · Bill

SF 5290: Addition requirement for certain pharmaceutical marketing expenses

In committee Last action May 13, 2026: Referred to Taxes

Plain-language summary

SF 5290 is a bill introduced in the Minnesota Senate on May 13, 2026. According to its official title, it concerns: Addition requirement for certain pharmaceutical marketing expenses. Primary sponsor: Matt Klein (Democratic-Farmer-Labor). Most recent recorded action (May 13, 2026): Referred to Taxes.

Sponsors

Primary sponsor: Matt Klein (Democratic-Farmer-Labor).